NSABPB40_3A: NSABPB40, figure 3A

NSABPB40_3AR Documentation

NSABPB40, figure 3A

Description

Kaplan-Meier digitized data from NSABPB40, figure 3A (PMID 26272770). A reported sample size of 1,206 for a primary endpoint of pCR in breast cancer.

Usage

NSABPB40_3A

Format

A data frame of 1,184 observations and 3 variables:

time event time (in years)
event DFS event indicator (0: no event, 1: event)
arm treatment arms (bev, no_bev)

Source

Bear HD, Tang G, Rastogi P, et al. Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial. Lancet Oncol 2015; 16: 1037–48.

Examples

summary(NSABPB40_3A)

kmplot(NSABPB40_3A)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.